Sign In
Free Newsletter
Pierre Fabre USA makes in-state HQ move to Secaucus
Pierre Fabre Laboratories relocated its stateside base from Parsippany to expand its dermo-cosmetics, rare disease and oncology efforts while staying rooted in New Jersey.
Johnson & Johnson completes $850M Proteologix acquisition
As part of the all-cash agreement, J&J assumes ownership of a collection of bispecific meds in development for moderate to severe atopic dermatitis.
J&J to acquire experimental eczema drug for $1.25B
The all-cash deal is the second the New Brunswick-based company announced this month for a treatment focused on the skin condition.
Timber Pharmaceuticals to be acquired by Danish giant in $36M deal
LEO Pharma will add the Warren-based clinical-stage biopharma company, which is focused on the development and commercialization of treatments for rare and orphan dermatologic diseases.
New dermatology center opens in South Jersey
The Dermatology of Philadelphia made its first expansion into the Garden State and also welcomed Dr. Jaryd Freedman to its team of board-certified physicians.
